COCAINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cocaine hydrochloride and what is the scope of patent protection?
Cocaine hydrochloride
is the generic ingredient in two branded drugs marketed by Genus Lifesciences and Omnivium Pharms, and is included in two NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for cocaine hydrochloride. Four suppliers are listed for this compound.
Summary for COCAINE HYDROCHLORIDE
US Patents: | 12 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Clinical Trials: | 477 |
Patent Applications: | 823 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for COCAINE HYDROCHLORIDE |
What excipients (inactive ingredients) are in COCAINE HYDROCHLORIDE? | COCAINE HYDROCHLORIDE excipients list |
DailyMed Link: | COCAINE HYDROCHLORIDE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for COCAINE HYDROCHLORIDE
Generic Entry Dates for COCAINE HYDROCHLORIDE*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;NASAL |
Generic Entry Dates for COCAINE HYDROCHLORIDE*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;NASAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for COCAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Radboud University Medical Center | Phase 2 |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 |
Parnassia Addiction Research Centre | Phase 2 |